Novel Coronavirus Treatment(BK7501),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

BK7501 Novel Coronavirus Treatment

Trading 04-17 12:28:41 AEST

849.46

-4.64

-0.54%

High856.27	Low848.44	Vol16.50M
Open854.66	D1 Closing854.10	Amplitude0.92%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O267.18M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":849.4602,"timestamp":1776392920722,"preClose":854.1034,"halted":0,"volume":16497656,"delay":0,"changeRate":-0.005436,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-4.643188,"latestTime":"04-17 12:28:41 AEST","open":854.6579,"high":856.26514,"low":848.44446,"amount":267184575,"amplitude":0.009157,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776405600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776384000000,1776405600000]],"turnoverRate":0.001155,"increases":5,"decrements":14,"flats":12,"marketCap":213902885644.25,"floatMarketCap":170462374886.33594},"requestUrl":"/m/hq/s/BK7501/wiki","defaultTab":"wiki","newsList":[{"id":"2628109572","title":"Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2628109572","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628109572?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:08","pubTimestamp":1776348536,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) recently secured an exclusive worldwide license to a patented chimeric antigen receptor technology from Mayo Clinic, with the goal of refining the targeting and immune effects of its mesenchymal stromal cell therapies.\nSee our latest analysis for Mesoblast.\nAt a share price of A$2.24, Mesoblast has seen a 10.89% 1 month share price return and a 10.34% 7 day share price return. Over 90 days, the share price return is a 15.15% decline, while the 3 year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-new-car-technology-licen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-new-car-technology-licen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB","MSB.AU","BK7508","BK7501","BK4006","CAR","BK4022","BK7067","BK4230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627261590","title":"Atomo Diagnostics Ltd-Share Purchase Plan Offer Opens","url":"https://stock-news.laohu8.com/highlight/detail?id=2627261590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627261590?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:19","pubTimestamp":1776320389,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUE8L5Z0Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AT1.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627692852","title":"Atomo Diagnostics Ltd-Share Purchase Plan Prospectus","url":"https://stock-news.laohu8.com/highlight/detail?id=2627692852","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627692852?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:02","pubTimestamp":1776319339,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUE6YYYKJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7501","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627126616","title":"BUZZ-Australia's Genetic Signatures extends gain on deal with Danish hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2627126616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627126616?lang=en_us&edition=fundamental","pubTime":"2026-04-16 13:26","pubTimestamp":1776317193,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures extends gain on deal with Danish hospital** Shares of molecular diagnostics firm Genetic Signatures GSS.AX rise 7.1% to A$0.15, their highest level since Feb 6** St","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nL4N40Z0E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627252448","title":"BRIEF-Woolworths Says Big W Drops Prices On Over 2,000 Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2627252448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627252448?lang=en_us&edition=fundamental","pubTime":"2026-04-16 09:43","pubTimestamp":1776303817,"startTime":"0","endTime":"0","summary":"BRIEF-Woolworths Says Big W Drops Prices On Over 2,000 ProductsApril 16  - Woolworths Group Ltd WOW.AX:BIG W DROPS PRICES ON OVER 2,000 PRODUCTS TO HELP CUSTOMERS SAVE ON FAMILY FAVOURITESFROM 16 APRIL SHELF PRICES ON PRODUCTS SPANNING SKINCARE, BEAUTY, OTHERS WILL DROP BY AVERAGE OF 13.5%Further company coverage: WOW.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nFWN40Y0J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7040","WOW.AU","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627252996","title":"Ansell Says CFO Brian Montgomery Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2627252996","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627252996?lang=en_us&edition=fundamental","pubTime":"2026-04-16 09:35","pubTimestamp":1776303329,"startTime":"0","endTime":"0","summary":"April 16 (Reuters) - Ansell Ltd ::*ANSELL LTD-CHIEF FINANCIAL OFFICER RESIGNATION*BRIAN MONTGOMERY RESIGNS AS ANSELL CFO TO JOIN HOLOGIC AS CFO*FRED MARX APPOINTED ACTING CFO OF ANSELL*Further company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nRSD3sKtwP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANN.AU","LU2433249047.HKD","LU0823416689.USD","BK4588","LU1923622614.USD","BK7501","LU1951200564.SGD","LU2125909247.SGD","BK4082","BK7126","LU2125909593.SGD","LU0314104364.USD","LU1923623000.USD","LU1951198990.SGD","HOLX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627960254","title":"CSL Bulls See Valuation Support Despite Challenges -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2627960254","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627960254?lang=en_us&edition=fundamental","pubTime":"2026-04-16 09:08","pubTimestamp":1776301680,"startTime":"0","endTime":"0","summary":"0108 GMT - CSL's bulls at UBS continue to see valuation support for the stock despite challenges from pricing, demand, and energy costs. The investment bank's analysts keep a buy rating on the vaccine and blood-products manufacturer, citing structurally sound demand for immunoglobulin and unchanged medium-term growth assumptions. They tell clients in a note that temporary oversupply in the U.S. is weighing on pricing but expect subdued plasma collections to help address this. Less positively, they see little evidence of the recovery in Chinese demand necessary to improve albumin sales growth. Cost inflation is also an emerging headwind, they add. UBS cuts its target price by 13% to A$205.00. Shares are down 2.1% at A$136.58. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004303.SGD","CSL.AU","BK7508","BK7067","LU1169590202.USD","BK7511","LU0728928796.USD","CSL","LU1169589451.USD","BK7501","SGXZ23171101.USD","BK4086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627256652","title":"Ansell CFO Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2627256652","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627256652?lang=en_us&edition=fundamental","pubTime":"2026-04-16 07:16","pubTimestamp":1776295007,"startTime":"0","endTime":"0","summary":"Ansell  said Chief Financial Officer Brian Montgomery resigned to join US-based medical technology company, Hologic, according to a Thursday filing with the Australian bourse.Vice President Fred Marx will be the acting CFO while the company looks for Montgomery's permanent successor, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANN.AU","BK7501","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627255739","title":"Woolworths - From 16 April Shelf Prices on Products Spanning Skincare, Beauty, Others Will Drop by Average of 13.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627255739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627255739?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:51","pubTimestamp":1776293461,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0J9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7040","WOW.AU","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627255732","title":"Woolworths - Big W Drops Prices on Over 2,000 Products to Help Customers Save on Family Favourites","url":"https://stock-news.laohu8.com/highlight/detail?id=2627255732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627255732?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:51","pubTimestamp":1776293461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7040","WOW.AU","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627551382","title":"Ansell Ltd-Chief Financial Officer Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2627551382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627551382?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:38","pubTimestamp":1776292739,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUE25CVG6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","ANN.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627255132","title":"Ansell Ltd - Brian Montgomery Resigns as Ansell CFO to Join Hologic as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2627255132","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627255132?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:38","pubTimestamp":1776292739,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUE25CVG6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANN.AU","BK7501","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627137255","title":"Ansell Ltd - Fred Marx Appointed Acting CFO of Ansell","url":"https://stock-news.laohu8.com/highlight/detail?id=2627137255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627137255?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:38","pubTimestamp":1776292739,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUE25CVG6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANN.AU","BK7501","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627020774","title":"Ansell’s Share Cancellation Prompts Fresh Look At Valuation And Shareholder Value Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2627020774","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627020774?lang=en_us&edition=fundamental","pubTime":"2026-04-15 15:07","pubTimestamp":1776236869,"startTime":"0","endTime":"0","summary":"Why Ansell’s latest share cancellation matters for investors\nAnsell (ASX:ANN) has cancelled around 1.03 million ordinary shares as part of its on-market buyback. This is a capital management move aimed at reducing the number of shares on issue and potentially increasing earnings per share.\nSee our latest analysis for Ansell.\nAt a share price of A$28.77, Ansell’s recent 90 day share price return of a 15.01% decline and year to date weakness contrast with a slightly positive 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/ansells-share-cancellation-prompts-fresh-look-at-valuation-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/ansells-share-cancellation-prompts-fresh-look-at-valuation-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ANN.AU","BK7126","BK7501","PPE.AU","BK7057"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472392","title":"BUZZ-Australia's Genetic Signatures jumps on supply agreement with Denmark hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472392","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627472392?lang=en_us&edition=fundamental","pubTime":"2026-04-15 11:31","pubTimestamp":1776223868,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures jumps on supply agreement with Denmark hospital** Shares of Genetic Signatures GSS.AX rise as much as 23.5% to A$0.1, their highest level since March 6** Logs steepest intraday pct rise since March 2** The molecular diagnostics firm signs agreements for the supply of equipment, reagents and consumables for gastrointestinal screening at Hvidovre Hospital in Denmark** About 638,000 shares change hands, 1.6 times the 30-day avg** Down 60.4% YTD, including the session's moves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL6N40Y089:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627479669","title":"BRIEF-Noxopharm Appoints Dr Olivier Laczka As New CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2627479669","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627479669?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:51","pubTimestamp":1776217913,"startTime":"0","endTime":"0","summary":"BRIEF-Noxopharm Appoints Dr Olivier Laczka As New CEOApril 15 (Reuters) - Noxopharm Ltd NOX.AX:NOXOPHARM APPOINTS DR OLIVIER LACZKA AS NEW CEOFurther company coverage: NOX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUE3XSWDC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","NOX.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627476087","title":"Mesoblast Acquires Exclusive License to Chimeric Antigen Receptor Platform; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627476087","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627476087?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:35","pubTimestamp":1776216917,"startTime":"0","endTime":"0","summary":"Mesoblast  acquired an exclusive license to a patented chimeric antigen receptor technology platform to boost the effectiveness of its products, according to a Wednesday filing with the Australian bourse.The company obtained the rights to the intellectual property developed at Mayo Clinic through the acquisition of a startup mainly formed to advance the technology, the filing said.Shares rose nearly 7% in morning trade Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","MSB.AU","BK7067","MESO","BK7501","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627476272","title":"Australian stocks edge higher as investors focus on US-Iran talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2627476272","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627476272?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:30","pubTimestamp":1776216641,"startTime":"0","endTime":"0","summary":"Australian stocks edge higher as investors focus on US-Iran talks April 15 (Reuters) - Australian shares rose for a second straight session on Wednesday, with miners leading the rally, as signs that d","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4N40Y012:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7135","BK7067","BK7511","BK7506","BK7508","MSB.AU","NST.AU","BK7030","EVN.AU","BHP.AU","BK7507","VGN.AU","CBA.AU","BK7095","BK7104","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627476379","title":"Australian superannuation fund HESTA names ESSSuper chief Robbie Campo as next CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2627476379","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627476379?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:15","pubTimestamp":1776215730,"startTime":"0","endTime":"0","summary":"Australian superannuation fund HESTA names ESSSuper chief Robbie Campo as next CEO April 15 (Reuters) - HESTA, an Australian health sector superannuation fund, said on Wednesday that it has appointed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4N40Y011:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BHP.AU","BK7095","BK7508","CSL.AU","BK7507"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627631475","title":"BUZZ-Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2627631475","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627631475?lang=en_us&edition=fundamental","pubTime":"2026-04-15 08:47","pubTimestamp":1776214056,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech** Shares of Mesoblast MSB.AX rise as much as 6% to A$2.13, post their biggest intraday pct gain since March 25** Drug maker acquires exclusive licence to patented chimeric antigen receptor  technology platform ** CAR tech for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell products** Foundational work on the technology was developed by investigators at U.S.-based Mayo Clinic** YTD, MSB down 22.4%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4N40Y01C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MSB.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0157},{"period":"6month","weight":0.0397},{"period":"1year","weight":0.192},{"period":"ytd","weight":0.0081}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7501","nameEN":"BK7501"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Novel Coronavirus Treatment(BK7501),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Novel Coronavirus Treatment(BK7501) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Novel Coronavirus Treatment,BK7501,Novel Coronavirus Treatment股票,Novel Coronavirus Treatment股票老虎,Novel Coronavirus Treatment股票老虎国际,Novel Coronavirus Treatment行情,Novel Coronavirus Treatment股票行情,Novel Coronavirus Treatment股价,Novel Coronavirus Treatment股市,Novel Coronavirus Treatment股票价格,Novel Coronavirus Treatment股票交易,Novel Coronavirus Treatment股票购买,Novel Coronavirus Treatment股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Novel Coronavirus Treatment(BK7501),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Novel Coronavirus Treatment(BK7501) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction